Insulin aspart, recombinant Subcutaneous and Pancreatin Capsules and Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pancreatin Capsules and Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pancreatin
Brand name: Hi-Vegi-Lip, Pancreatin 4X, Donnazyme, Digipepsin, Pan-2400
Synonyms: Pancreatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pancreaze
- Insulin aspart, recombinant Subcutaneous-Pancrelipase
- Insulin aspart, recombinant Subcutaneous-Pancrelipase Capsules
- Insulin aspart, recombinant Subcutaneous-Pancrelipase Tablets
- Insulin aspart, recombinant Subcutaneous-Pancuronium
- Insulin aspart, recombinant Subcutaneous-Pancuronium Bromide
- Pancreatin Capsules and Tablets-Insulin degludec
- Pancreatin Capsules and Tablets-Insulin Degludec (U-100) Prefilled Pens
- Pancreatin Capsules and Tablets-Insulin Degludec (U-100) Vials
- Pancreatin Capsules and Tablets-Insulin Degludec (U-200) Prefilled Pens
- Pancreatin Capsules and Tablets-Insulin degludec and liraglutide
- Pancreatin Capsules and Tablets-Insulin degludec and liraglutide Subcutaneous